Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea

NCT00126399 is registered in ClinicalTrials.gov with CollaGenex Pharmaceuticals as lead sponsor.

NCT NCT00126399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00126399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea
Lead sponsor
CollaGenex Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2004
Completion date
April 30, 2005
Enrollment
528
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rosacea